CH is associated with elevated levels of brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP), both of which are mediated by the stimulation of pathological hypertrophy pathways, such as those mediated by angiotensin II and endothelin-1 [9,10]. This evidence concerns the gene NPPA and cyclic hematopoiesis.